Ambev S.A. Files 6-K for Year-End 2025 Reporting

TL;DR

Ambev S.A. (ABEV) filed its 6-K for year-end 2025, confirming 20-F filing and Brazilian HQ.

AI Summary

Ambev S.A. filed a Form 6-K on December 9, 2025, reporting for the period ending December 31, 2025. The filing indicates Ambev S.A. is a foreign private issuer and will file its annual reports under Form 20-F. The company's principal executive office is located in Sao Paulo, Brazil.

Why It Matters

This filing provides an update on Ambev S.A.'s reporting status and confirms their adherence to SEC regulations for foreign private issuers. It signals ongoing compliance and transparency for investors.

Risk Assessment

Risk Level: low — This is a routine filing confirming reporting status and location, with no new financial or operational information presented.

Key Players & Entities

• AMBEV S.A. (company) — Registrant
• 0001292814-25-004188 (other) — Accession Number
• 20251231 (date) — Period of Report
• 20251209 (date) — Filing Date
• Sao Paulo, Brazil (location) — Principal Executive Office
• Form 20-F (document) — Annual Report Filing Type
• InBev Corporate Holdings Inc. (company) — Former Company Name

FAQ

Filing Documents

• abevcvm358nov25_6k.htm (6-K) — 76KB
• 0001292814-25-004188.txt ( ) — 77KB

From the Filing

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of December, 2025 Commission File Number 1565025 AMBEV S.A. (Exact name of registrant as specified in its charter) AMBEV S.A. (Translation of Registrant's name into English) Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor 04530-000 São Paulo, SP Federative Republic of Brazil (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ___X___ Form 40-F _______ Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes _______ No ___X____ CONSOLIDATED FORM Management and Related Persons' Transactions of Securities Issued by the Company Article 11 - CVM Instruction # 358/2002 From November 1 st to 30 th , 2025 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002 (1) : Company Name: Ambev S.A. Group and Related Persons ( X ) Board of Directors ( ) Management ( ) Fiscal Council ( ) Technical and Consulting Committees Initial Balance Securities / Derivatives Securities Characteristics (2) Quantity Shares Common 12,107,569 ADR Common 468,040 Transactions in the month Securities / Derivatives Securities Characteristics (2) Intermediary Operation Day Quantity Price Volume (R$) (3) Final Balance Securities / Derivatives Securities Characteristics (2) Quantity Shares Common 12,107,569 ADR Common 468,040 (1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information. (2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others. (3) Quantity multiplied by price. Note: These consolidated data must have information by group: Directors, Management (which have not been included in the Board of Directors), etc. Each ADR is equivalent to 1 (one) share. CONSOLIDATED FORM Management and Related Persons' Transactions of Securities Issued by the Company Article 11 - CVM Instruction # 358/2002 November 1 st to 30 th , 2025 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002 (1) : Company Name: Ambev S.A. Group and Related Persons ( ) Board of Directors ( X ) Management ( ) Fiscal Council ( ) Technical and Consulting Committees Initial Balance Securities / Derivatives Securities Characteristics (2) Quantity Shares Common 3,783,056 ADR Common 19,790 Transactions in the month Securities / Derivatives Securities Characteristics (2) Intermediary Operation Day Quantity Price Volume (R$) (3) Final Balance Securities / Derivatives Securities Characteristics (2) Quantity Shares Common 3,783,056 ADR Common 19,790 (1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information. (2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others. (3) Quantity multiplied by price. Note: These consolidated data must have information by group: Directors, Management (which have not been included in the Board of Directors), etc. Each ADR is equivalent to 1 (one) share. CONSOLIDATED FORM Management and Related Persons' Transactions of Securities Issued by the Company Article 11 - CVM Instruction # 358/2002 November 1 st to 30 th , 2025 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002 (1) : Company Name: Ambev S.A. Group and Related Persons ( ) Board of Directors ( ) Management ( X ) Fiscal Council ( ) Technical and Consulting Committees Initial Balance Securities / Derivatives Securities Characteristics (2) Quantity Shares Common 2,500 Transactions in the month Securities / Derivatives Securities Characteristics (2) Intermediary Operation Day Quantity Price Volume (R$) (3) Final Balance Securities / Derivatives Securities Characteristics (2) Quantity Shares Common 2,500 (1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information

View Full Filing

View this 6-K filing on SEC EDGAR